CAPROCK Group Inc. Boosts Position in CME Group Inc (CME)

CAPROCK Group Inc. increased its stake in shares of CME Group Inc (NASDAQ:CME) by 8.3% during the first quarter, Holdings Channel reports. The institutional investor owned 5,737 shares of the financial services provider’s stock after buying an additional 440 shares during the period. CAPROCK Group Inc.’s holdings in CME Group were worth $682,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the stock. Hudock Capital Group LLC boosted its stake in shares of CME Group by 0.5% in the third quarter. Hudock Capital Group LLC now owns 3,726 shares of the financial services provider’s stock valued at $389,000 after buying an additional 20 shares during the period. Investec Asset Management PTY Ltd boosted its stake in shares of CME Group by 0.3% in the fourth quarter. Investec Asset Management PTY Ltd now owns 7,790 shares of the financial services provider’s stock valued at $900,000 after buying an additional 26 shares during the period. Huntington National Bank boosted its stake in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock valued at $100,000 after buying an additional 38 shares during the period. Johnson Financial Group Inc. boosted its stake in shares of CME Group by 5.9% in the fourth quarter. Johnson Financial Group Inc. now owns 899 shares of the financial services provider’s stock valued at $104,000 after buying an additional 50 shares during the period. Finally, Pekin Singer Strauss Asset Management IL boosted its stake in shares of CME Group by 0.5% in the third quarter. Pekin Singer Strauss Asset Management IL now owns 13,875 shares of the financial services provider’s stock valued at $1,450,000 after buying an additional 64 shares during the period. 80.06% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Shares of CME Group Inc (NASDAQ:CME) traded down 0.29% on Friday, reaching $118.77. 1,302,617 shares of the company were exchanged. CME Group Inc has a 12-month low of $90.69 and a 12-month high of $127.60. The company’s 50 day moving average is $120.33 and its 200 day moving average is $115.89. The firm has a market capitalization of $40.34 billion, a PE ratio of 26.22 and a beta of 0.88.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, February 2nd. The financial services provider reported $1.14 EPS for the quarter, beating the consensus estimate of $1.11 by $0.03. The company earned $913 million during the quarter, compared to analysts’ expectations of $881.46 million. CME Group had a net margin of 42.67% and a return on equity of 7.28%. CME Group’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.92 earnings per share. Analysts forecast that CME Group Inc will post $4.84 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 27th. Investors of record on Friday, March 10th were paid a dividend of $0.66 per share. The ex-dividend date was Wednesday, March 8th. This represents a $2.64 annualized dividend and a yield of 2.22%. This is a boost from CME Group’s previous quarterly dividend of $0.60. CME Group’s payout ratio is currently 52.98%.

TRADEMARK VIOLATION WARNING: “CAPROCK Group Inc. Boosts Position in CME Group Inc (CME)” was published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/2486105/caprock-group-inc-boosts-position-in-cme-group-inc-cme.html.

CME has been the topic of several analyst reports. Jefferies Group LLC reissued a “buy” rating and set a $128.00 price target on shares of CME Group in a research report on Saturday, March 11th. Deutsche Bank AG boosted their price target on shares of CME Group from $136.00 to $137.00 and gave the stock a “buy” rating in a research report on Tuesday. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, January 10th. JPMorgan Chase & Co. cut shares of CME Group from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 31st. Finally, Royal Bank of Canada lowered their price objective on shares of CME Group from $134.00 to $133.00 and set an “outperform” rating on the stock in a research note on Wednesday. One analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $111.54.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, April 10th. The shares were sold at an average price of $117.85, for a total value of $294,625.00. Following the completion of the transaction, the chief financial officer now owns 40,995 shares of the company’s stock, valued at approximately $4,831,260.75. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Dennis Suskind sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, February 3rd. The stock was sold at an average price of $121.00, for a total transaction of $121,000.00. Following the completion of the transaction, the director now directly owns 6,099 shares of the company’s stock, valued at approximately $737,979. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,931 shares of company stock valued at $1,576,260. 0.61% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

5 Day Chart for NASDAQ:CME

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Shares at Radius Jump as Bone Drug of Amgen Has Setback
Blackberry Returns as Stock Surges Following WannaCry
Blackberry Returns as Stock Surges Following WannaCry
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
Flight Attendants Accuse Frontier Airlines of Not Allowing Breast Feeding
General Motors’ Maven Launches in New York City
General Motors’ Maven Launches in New York City
Hyundai and Kia Recall Ordered by South Korea Officials
Hyundai and Kia Recall Ordered by South Korea Officials


© 2006-2017 Ticker Report. Google+.